Ghebeh, H.; Mirza, J.Y.; Al-Tweigeri, T.; Al-Alwan, M.; Tulbah, A.
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy. Int. J. Mol. Sci. 2025, 26, 8219.
https://doi.org/10.3390/ijms26178219
AMA Style
Ghebeh H, Mirza JY, Al-Tweigeri T, Al-Alwan M, Tulbah A.
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy. International Journal of Molecular Sciences. 2025; 26(17):8219.
https://doi.org/10.3390/ijms26178219
Chicago/Turabian Style
Ghebeh, Hazem, Jumanah Y. Mirza, Taher Al-Tweigeri, Monther Al-Alwan, and Asma Tulbah.
2025. "Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy" International Journal of Molecular Sciences 26, no. 17: 8219.
https://doi.org/10.3390/ijms26178219
APA Style
Ghebeh, H., Mirza, J. Y., Al-Tweigeri, T., Al-Alwan, M., & Tulbah, A.
(2025). Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy. International Journal of Molecular Sciences, 26(17), 8219.
https://doi.org/10.3390/ijms26178219